AC Immune SA is a clinical-stage biopharma that aims to become a global leader in precision medicine for neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and NeuroOrphan indications. The Company has two clinically validated technology platforms, SupraAntigen® and Morphomer®.
Cooperation possibilities
AC Immune’s expertise and proprietary cutting-edge technologies enable the discovery of first- and best-in-class candidates. The Company has a strong track record of securing strategic partnerships with leading global pharmaceutical companies, which maximizes the value of its diversified pipeline.
- http://www.acimmune.com
- +41 21 345 91 21
- yves.kremer@acimmune.com
- Andrea Pfeifer
